Is it troublesome for a medical device company to change its address? From the perspective of actual operation, this question cannot be answered in a blanket way. Although the legal procedure itself is not complicated, when special regulatory requirements of the industry are involved, enterprises need to be especially cautious. According to Article 7 of the Company Law, a change of enterprise domicile is a change in registration matters, and a company must apply to the market supervision and administration authority for change registration and replacement of its business license — this is a statutory obligation of the enterprise, but the process itself is actually orderly and traceable.
The specific operation can be divided into three key stages. First, the enterprise needs to prepare materials such as the application for change registration, the shareholders’ meeting resolution, and proof documents for the new address, such as the property ownership certificate or lease contract, and submit the application to the government service center. The author especially suggests paying attention to this point: different regions may have different requirements for address proof. For example, some regions require proof of lease filing or a letter of consent from the property owner. In 2023, when a well-known medical device enterprise moved from Pudong to Songjiang, it spent an additional five working days supplementing materials because it had not completed lease filing in advance — it can therefore be seen that whether the early-stage preparation is sufficient directly affects handling efficiency.
The second stage is the review by the regulatory authorities. The market supervision and administration authority will focus on verifying whether the new address is a lawful business premises and whether the lease relationship is true and valid. If the materials are complete and comply with the regulations, approval of the change can usually be obtained within three to five working days. However, it should be noted that medical device companies often involve change of the filing address for production permits, and if the move is across regions, a simultaneous filing with the drug regulatory authority is also required. For example, when an in vitro diagnostic reagent enterprise moved from Xuhui District to Minhang District in 2022, although the industrial and commercial change went through smoothly, it failed to update the filing address in the drug regulatory system in time, which resulted in a rectification notice being issued during a surprise inspection.
The final stage is collecting the new business license and carrying out subsequent supporting updates. After obtaining the new license, the enterprise must, within ten days, simultaneously update its tax registration, bank account information, and the filing address on its medical device registration certificate and other relevant records. A common problem in practice is that many enterprises attach importance to industrial and commercial changes but neglect subsequent coordination. In 2021, a surgical instrument manufacturer failed to promptly update the filing address for its customs declaration entity, causing a batch of imported raw materials to be stranded at the port for one week and resulting in huge demurrage charges. The author believes that such derivative problems often consume more energy than the main change itself.
Overall, the answer to the question “Is it troublesome for a medical device company to change its address?” depends on the enterprise’s compliance awareness and execution ability.
Overall, the answer to the question “Is it troublesome for a medical device company to change its address?” depends on the enterprise’s compliance awareness and execution ability. If material preparation is completed in advance and cross-department filing procedures are properly coordinated, the actual operation is not difficult. However, if the regulatory characteristics of the industry are ignored, chain reactions may be triggered. It is recommended that enterprises entrust professional advisors to conduct compliance assessments of the new site, especially with respect to special requirements such as clean workshops, and establish a cross-department coordinated change checklist.
Question for consideration: If, after relocation, the operating area of a medical device company is expanded by 30%, is it necessary to undergo a new on-site GMP certification inspection?